Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05763888
Other study ID # NB220039-NB
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 12, 2023
Est. completion date May 1, 2023

Study information

Verified date May 2023
Source NovoBliss Research Pvt Ltd
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

An exploratory approach for validation and standardization of test methods and evaluators to conduct In-Vivo clinical safety and efficacy testing of hair care range of products. A total of 40 subjects will be enrolled.


Description:

This is an internal standardization and validation study. This standardization and validation study will be carried out by the trainee evaluators' of NovoBliss Research who voluntarily wish to take part in this study. There are multiple techniques for establishing documentary evidence demonstrating that standardised procedural steps, processes and methods are carried out in testing for hairs care range of products to maintain the desired level of compliance. It is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results. The desired results are established in terms of specifications for the outcome of the processes. Below listed test methods/techniques will be performed: - Assessment of General appearance of hair (i.e. Hair Volume, Hair Density, Hair Reflection, Hair Plasticity, Hair Smoothness, Hair Oiliness, Shininess) - Assessment of Scalp Appearance i.e. itchiness, dryness, redness, roughness, and scaliness of scalp - Assessment of Adherent Scalp Flaking Score (ASFS) - Assessment of Hair Strength (i.e. Poor, Average, Good) - Assessment of Gray Hair - Graying Severity Score (GSS); Hair Whitening Score. Evaluation Methods - 60-seconds hair count (Hair Combing Method) - Hair Pull Test - Trichogram (Pluck Test - Anagen: Telogen Ratio Calculation) - Scanning Electron Microscope (SEM) Instrumental Evaluation: - Phototrichogram - Tattoo Method for Hair Growth Rate, Hair Density, Hair Thickness, and Scalp Condition i.e. Scalp Dandruff - Using CASLite Nova - Scalp Hydration by MoistureMeterEpiD - Scalp Sebum level by Sebumeter - Hair Color by Hair/Skin Colorimeter CL 410 - Image analysis for Hair Growth Rates, number of hairs and length, and Gray hair counts, using Image-Pro Software - Assessment of Hair Cuticle - by Electron microscope to check parameters such as surface damage of hair, photodamage of outermost cuticle layer - Microbial changes in scalp flora by trichoscopy or dermoscopy.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date May 1, 2023
Est. primary completion date May 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria: 1. Age: 18 - 75 years (both inclusive) at the time of consent. 2. Sex: Males and non-pregnant/non-lactating females (preferably equal number of males and females). 3. Females of childbearing potential must have a self-reported negative urine pregnancy. 4. Subject is in good general health as determined by the Investigator on the basis of medical history. 5. Subject is willing and able to follow and allow study staff to performed study test methods 6. Subject is willing and able to follow the study directions, to participate in the study, returning for all specified visits. 7. Subject must be able to understand and provide written informed consent to participate in the study. Exclusion Criteria: 1. Subject have history of allergy to any ink. 2. Subject have participated any clinical research study related to hair care products. 3. Subject having history of diabetes 4. Subject have history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months. 5. Subject having known history of any skin diseases including eczema, atopic dermatitis or active cancer.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No drug will given
No intervention will be given to the subject

Locations

Country Name City State
India NovoBliss Research Pvt Ltd Gandhinagar Gujarat

Sponsors (1)

Lead Sponsor Collaborator
NovoBliss Research Pvt Ltd

Country where clinical trial is conducted

India, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluate the standardize the methods, procedural steps Validate the hair growth rate measurement Day 01 to Day 04
Primary Evaluate the standardize the methods, procedural steps 60-s combing test Day 01 to Day 04
Primary Evaluate the standardize the methods, procedural steps Hair Pull test Day 01 to Day 04
Primary Evaluate the standardize the methods, procedural steps Hair Pluck test Day 01 to Day 04
Primary Evaluate the standardize the methods, procedural steps Subjective scoring of Hair quality appearance and scalp condition Day 01 to Day 04
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02664883 - Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
Completed NCT05611281 - GS3-007a Oral Solution in Healthy Subjects Phase 1
Completed NCT03457480 - Text Messages in Preventing Tobacco Use in Young Adults N/A
Completed NCT05358756 - A Study of Bioavailability and Food Effect of SACT-1 and Edurant® Tablets in Healthy Adult Volunteers Phase 1
Completed NCT06037395 - Phase I Study to Compare the Pharmacokinetics, Pharmacodynamics, and Safety Between CT-P41 and US-licensed Prolia in Healthy Male Subjects Phase 1
Active, not recruiting NCT04032106 - HPV Vaccine Intervention for Young Sexual Minority Men N/A
Completed NCT04062955 - Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants N/A
Recruiting NCT03897270 - Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects N/A
Completed NCT01846520 - Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers N/A
Completed NCT02960100 - mHealth Intervention in Increasing HPV Vaccinations in College Students N/A
Completed NCT03698318 - Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts N/A
Completed NCT05497635 - A Study of STSA-1002 in Healthy Subjects Phase 1
Active, not recruiting NCT03303846 - Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients N/A
Recruiting NCT05559125 - A Study of STSA-1002 Combined With STSA-1005 in Healthy Subjects Phase 1
Completed NCT03584100 - Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal N/A
Recruiting NCT05117385 - The Effect of the Consumption of 4 Botanical Extracts on Immunity in Healthy Adults (B-4-Immune) N/A
Active, not recruiting NCT05660720 - Evaluate the Effect of Orelabrutinib on Cardiac Repolarization in Healthy Subjects Phase 1
Recruiting NCT03188848 - Dose Escalating Study of BPI-3016 in Healthy Subjects Phase 1
Completed NCT01908920 - Osteopathic Manipulative Treatment Effects on High Frequency Parameters in Healthy Subjects N/A
Active, not recruiting NCT03491176 - Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer N/A